BIOMAT Database Logo BIOMAT Database Logo

Synthesis and pharmacological evaluation of 1-isopropyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel antihypertensive agents. 2011

Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Drug Discovery Research, Astellas Pharma Inc., Japan. susumu.watanuki@jp.astellas.com

A series of 1-isopropyl-1,2,3,4-tetrahydroisoquinoline derivatives were synthesized and their bradycardic activities were evaluated in isolated guinea pig right atria. Structure-activity relationship studies revealed that the introduction of an appropriate substituent and its position on the 1,2,3,4-tetrahydroisoquinoline ring are essential for potent in vitro activity. Furthermore, the tether between the piperidyl moiety and the terminal aromatic ring is important for potent antihypertensive activity. Oral administration of 6-fluoro-1-isopropyl-2-{[1-(2-phenylethyl)piperidin-4-yl]carbonyl}-1,2,3,4-tetrahydroisoquinoline (3b) to spontaneously hypertensive rats (SHR) elicited antihypertensive effects without inducing reflex tachycardia, which is often caused by traditional L-type Ca²⁺ channel blockers.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
June 2004, Bioorganic & medicinal chemistry letters,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
March 2004, Bioorganic & medicinal chemistry,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agents.
April 2003, Chemical & pharmaceutical bulletin,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and in vitro evaluation of novel 1,2,3,4-tetrahydroisoquinoline derivatives as potent antiglioma agents.
March 2014, Anti-cancer agents in medicinal chemistry,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and pharmacological properties of 1,2,3,4-tetrahydroisoquinoline derivatives.
January 1996, Acta poloniae pharmaceutica,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and pharmacological investigations of 1,2,3,4-tetrahydroisoquinoline derivatives.
June 1996, Die Pharmazie,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES WITH ANTIHYPERTENSIVE PROPERTIES.
January 1965, Journal of medicinal chemistry,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.
March 2018, European journal of medicinal chemistry,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents.
February 2008, Chemical & pharmaceutical bulletin,
Susumu Watanuki, and Keisuke Matsuura, and Yuichi Tomura, and Minoru Okada, and Toshio Okazaki, and Mitsuaki Ohta, and Shin-Ichi Tsukamoto
Synthesis and pharmacological properties of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives.
January 1996, Acta poloniae pharmaceutica,
Copied contents to your clipboard!